Late Occurrence of PML in a Patient Treated for Lymphoma with Immunomodulatory Chemotherapies, Bendamustine, Rituximab, and Ibritumomab Tiuxetan

<div>(a) T2 FLAIR: confluent hyperintense lesion in R hemisphere over R frontal region, R motor cortex. Involvement of U fibers. Minimal perilesional edema. Few lesions are seen in left frontal region as well. (b) Sagittal T1 images show hypointense lesion in the left frontal regions corresponding to the axial images.</div>

Case Reports in Neurological Medicine

fig1

Figure 1

Figure 1: Late Occurrence of PML in a Patient Treated for Lymphoma with Immunomodulatory Chemotherapies, Bendamustine, Rituximab, and Ibritumomab Tiuxetan 

Figure 1 | Late Occurrence of PML in a Patient Treated for Lymphoma with Immunomodulatory Chemotherapies, Bendamustine, Rituximab, and Ibritumomab Tiuxetan 